Amanda S. Marshall
Former U.S. Attorney
(Local Counsel)
Lynette Byrd
Former Assistant
U.S. Attorney
Roger Bach
Former Special
Agent
(OIG & DEA)
Joe Brown
Former U.S. Attorney
Dr. Nick Oberheiden
Attorney & Founder
Compound Pharmacy Investigations
How Doctors Turn Defendants for Causing Medically Unnecessary Services If there is one major trend in federal healthcare fraud investigations in 2018 and 2019, it is the criminal prosecutions of medical providers and healthcare business owners for rendering medically unnecessary services. This brief article addresses how physicians, psychologists, psychiatrists, dentists,...
Read more
What Is the Difference Between a Physician Self-Referral and a Kickback?
For physicians and other healthcare providers, navigating the statutory and regulatory restrictions on billing for reimbursements from Medicare, Medicaid, Tricare, and other government benefit programs presents some of the greatest challenges – and risks – when it comes to legal compliance. Among the laws that apply are the Physician Self-Referral...
Read more
When Can Business Owners Be Held Personally Liable?
In federal healthcare fraud investigations and other federal cases targeting partnerships and corporate entities, one of the biggest questions for company owners is "Am I at risk of being held personally liable?" While the best-case scenario is to avoid liability all together, if any liability is going to be imposed,...
Read more
Bayer Paid Doctors Millions for Questionable Birth Control Device
July 8, 2018 Bayer Paid Doctors Millions for Questionable Birth Control Device Bayer AG, the pharmaceutical giant responsible for drugs and devices such as Aleve, Aspirin, and Yaz, is facing tens of thousands of lawsuits from women who claim that its new Essure birth control device is dangerous and defective....
Read more
What Kinds of Billing and Coding Errors Constitute Healthcare Fraud?
What are the consequences if you or your billing administrator commits a billing or coding error that results in an unjustified payment from Medicare, Medicaid, or Tricare? While you might assume that this type of honest mistake could be remedied fairly easily, in today's world of aggressive healthcare fraud enforcement,...
Read more
What Types of Activities Are Covered Under the False Claims Act?
The False Claims Act is a broad federal statute that covers a wide range of activities involving the submission of reimbursement claims under Medicare, Medicaid, Tricare, and other healthcare benefit programs. For this reason, it is one of the federal government's most potent weapons for prosecuting healthcare providers. It is...
Read more
Glossary: Understanding Your Federal Healthcare Fraud Investigation
Is your business or practice being targeted in a federal healthcare fraud investigation? If so, the federal healthcare fraud defense team at Oberheiden, P.C., is here to help. From acronyms to legalese, when you are facing a federal healthcare fraud investigation, you are likely to hear various terms with which...
Read more
How Can Pharmacists Be Charged with Prescription Drug Fraud?
Pharmacists are currently at high risk for being targeted in Federal Healthcare Fraud investigations. If your pharmacy or compound pharmacy is under investigation, we can help. When you went to pharmacy school, the last thing on your mind was the risk of being targeted in a federal investigation. As you...
Read more
Q&A with Federal Healthcare Fraud Defense Lawyer, Nick Oberheiden, PhD: What Do You Need to Know If Your Practice Is Under Investigation?
Dr. Nick Oberheiden is a highly experienced healthcare fraud defense lawyer who devotes his practice to representing clients in high-stakes federal investigations. Is your practice being targeted? If so, here's what you need to know. What do you need to know if your practice is under investigation for alleged fraudulent...
Read more
What Is the Prescription Interdiction & Litigation (PIL) Task Force?
The Prescription Interdiction & Litigation (PIL) Task Force is one of the DOJ's newest efforts to target healthcare providers as it seeks to combat the nation's opioid crisis. Earlier this year, the U.S. Department of Justice (DOJ) announced the formation of a new Prescription Interdiction & Litigation (PIL) Task Force....
Read more